PROTEOME SCIENCES plc
("Proteome Sciences" or the "Company")
PRESS RELEASE
Statement re Share Price Movement
The Board of Proteome Sciences has noted the recent movement in the Company's
share price and that they are not aware of any reason for the share price
increase.
In the trading update released on 21 December 2007, the Board reported that it
continued to view future prospects for TMT® commercialisation with increasing
confidence, with the related licence negotiations expected to be concluded in
early 2008. This remains the case and the Company will issue a further update
on licence negotiations in due course.
Ends
For further information please visit www.proteomics.com.
Proteome Sciences plc
Christopher Pearce James Malthouse
Chief Executive Officer Finance Director
[email protected] [email protected]
Tel: +44 (0)1932 865065
Public Relations
IKON Associates Coast Communications
Adrian Shaw Matt Baldwin
Tel: +44 (0)1483 535102 Tel: +44 (0)1233 503200
Mobile: +44 (0)797 9900733 Mobile: +44 (0)7930 439739
[email protected] [email protected]
Nominated Adviser
Landsbanki Securities (UK) Limited
Gareth Price / Thilo Hoffman Tel: +44 (0)20 7426 9000